Abstract
Purpose. The goal of this study was to determine if the co-administration of esmolol (ES), a short acting cardioselective β-blocker, significantly alters the pharmacokinetics and/or pharmacodynamics of remifentanil (REMI), an ultra short-acting opioid, in the rat.
Methods. Sprague-Dawley rats (N = 8, Wt. = 325 ± 15g) were surgically implanted with stainless steel cerebrocortical EEG electrodes three days before the study. Each rat was dosed with REMI (15 μg/ kg/min), and REMI & ES (15 μg/kg/min and 600 μg/kg/min) for 21 minutes in a random crossover design. Six serial blood samples were collected over 25 minutes into test-tubes containing 0.5ml acetonitrile. Blood samples were extracted with methylene chloride and analyzed by a validated GC-MS assay. EEG was captured and subjected to power spectral analysis (0.1−50 Hz) for spectral edge (97%).
Results. No significant differences (p < 0.05) were found in clearance (REMI = 287 + 73 ml/min/leg vs. REMI & ES = 289 ± 148 ml/ min kg) or Vd (REMI = 286 ± 49 ml/kg vs REMI & ES = 248 + 40 ml/kg). A linked sigmoid Emax PK-PD model was used and the pharmacodynamic parameters were not statistically different. Mean Emax and EC50 after REMI were 18.0 ± 6.0 Hz and 32 ± 12 ng/ml; and after REMI + ES were 19 + 4.8 Hz and 26 + 8.6 ng/ml.
Conclusions. At the doses tested, there is no pharmacokinetic or pharmacodynamic interaction between remifentanil and esmolol in the rat.
Similar content being viewed by others
REFERENCES
A. H. Amin, A. M. Sopchak, B. F. Esposito, L. G. Henson, R. L. Batenhorst, A. W. Fox, and E. M. Camporesi. J. Pharmacol. Exp. Therap. 274:34–39 (1995).
T. D. Egan, H. J. Lemmens, P. Fiset, D. J. Hermann, K. T. Muir, D. R. Stansky, and S. L. Shafter. L. Anesthesiology 79:881–892 (1993).
J. F. Hoke, K. T. Muir, P. S. A. Glass, D. Shlugman, C. E. Rosow, C. E., M. Dershwitz, and P. Michalowski. Clin. Pharm. Ther. 57:148 (1995).
M. Dershwitz, J. F. Hoke, C. E. Rosow, P. Michalowski, P. M. Connors, K. T. Muir, and J. L. Dienstag. Anesthesiology 84:812–820 (1996).
C. L. Westmoreland, J. F. Hoke, P. S. Sebel, C. C. Hug, and K. T. Muir. Anesthesiology 79:893–903 (1993).
P. S. A. Glass, D. Hardman, Y. Kamiyama, T. J. Quill, G. Marton, K. H. Donn, C. M. Grosse, and D. Hermann. Anesth. Analg. 77:1031–1040 (1993).
T. D. Egan, C. F. Minto, D. J. Hermann, J. Barr, K. T. Muir, and S. L. Shafer, S. L. Anesthesiology 84:821–833 (1996).
S. K. Pandit and C. R. Green. International Anesth. Clinics 32:55–79 (1994).
S. L. Shafer and J. R. Varvel. Anesthesiology. 74:53–63 (1991).
J. C. Scott, K. V. Ponganis, and D. R. Stanski. Anesthesiology. 62:234–241 (1985).
J. C. Scott, J. E. Cooke, and D. R. Stanski. Anesthesiology. 74:34–42 (1991).
P. S. Sebel, J. G. Bovill, A. Wauquier, and P. Rog. Anesthesiology. 55:203–211 (1981).
W. E. Hoffman, F. Cunningham, M. K. James, V. L. Baughman, and R. F. Albrecht. Anesthesiology 79:107–113 (1993).
F. E. Cunningham, W. E. Hoffman, and V. L. Baughman. Anesthesiology 79:A712 (1993).
R. D. Reynolds, R. J. Gorczynski, and C. Y. Quon. J. Clin. Pharmacol. 26(suppl A):A3–A14, (1986).
C. Y. Quon and R. J. Gorczynski. J. Pharmacol. Exp. Ther. 237:912–918 (1986).
C. M. Grosse; I. M. Davis, R. F. Arrendale, J. Jersey, and J. Amin. J. Pharm. Biomed. Anal. 12:195–203 (1993).
N. Khazan. Methods in Narcotics Research, ed. by S. Ehrenpreis and A. Neidle, pp. 173–215, Marcel Dekker Inc., New York, 1975.
R. J. Lozito, S. La Marca, R. W. Dunn, and T. P. Jerussi. Life Sci. 55:1337–1342 (1994).
G. E. Schumacher and J. T. Barr. Clin. Pharm. 3:525–530 (1984).
L. B. Sheiner, S. Beal, B. Rosenberg, and V. Marathe. Clin. Pharmacol. Ther. 26:294–305 (1979).
L. B. Sheiner and S. L. Beal. J. Pharm. Sci. 71:1344–1348 (1982).
D. Z. D'Argenio and A. Schumitsky. Biomedical Simulations Resource, University of Southern California, Los Angeles, CA (1992).
S. H. Haidar, J. E. Moreton, Z. Liang, J. F. Hoke, K. T. Muir, and N. D. Eddington. J. Pharm. Sci. (in press)
J. C. Scott, K. V. Ponganis, and D. R. Stanski. Anesthesiology. 62:234–241 (1985).
N. H. G. Holford and L. B. Sheiner. Clin. Pharmacokinet. 6:429–453 (1981).
R. J. Gorczynski, J. Shaffer, and R. J. Lee. J. Cardiovasc. Pharmacol. 5:668–677 (1983).
C. Y. Quon and H. F. Stampfli. Drug Metab. Dispos. 13:420–424 (1985).
C. Y. Quon, K. Mai, G. Patil, and H. f. Stampfli. Drug Metab. Dispos. 16:425–428 (1988).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Haidar, S.H., Moreton, J.E., Liang, Z. et al. The Pharmacokinetics and Electroencephalogram Response of Remifentanil Alone and in Combination with Esmolol in the Rat. Pharm Res 14, 1817–1823 (1997). https://doi.org/10.1023/A:1012156502624
Issue Date:
DOI: https://doi.org/10.1023/A:1012156502624